4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-029451
President and Chief Executive bought 20,500 shares at $7.41 ($151,835)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2022-05-13 | Purchase | +20,500 | $7.41 | $151,835 | 64,595 | D |
| Open-market purchases · 20,500 sh · avg $7.41 · $151,835 | |||||||
Loading xslF345X03/doc4.xml…